Showing results (361-370 of 5,440) with videos related to
Sort By:
Pageof 544
Bulletin Du Cancer|January 1, 1983
[Nasopharyngeal epitheliomas: experience of the Regional Cancer Control Center in Lille (79 cases 1970-1982)]J L Lefebvre, M Madelain, L Adenis, et al.Bulletin Du Cancer|January 1, 1983
[Cancer of the rectum: current trends in radiotherapy in conservative treatment]J Papillon, M Mayer, J L Chassard, et al.Bulletin Du Cancer|January 1, 1983
[Acute leukemias and solid tumors in the course of Hodgkin disease]C Jacquillat, G Auclerc, M Weil, et al.Bulletin Du Cancer|January 1, 1981
[Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)]J Chauvergne, M Durand, R Brunet, et al.Bulletin Du Cancer|January 1, 1984
Ewing's sarcoma: value of tumor necrosis as a predictive factorE de Stéfani, J Carzoglio, H Deneo Pellegrini, et al.Bulletin Du Cancer|January 1, 1984
[The use of the pectoralis major myocutaneous flap in cervicofacial and particularly buccopharyngeal, surgery. Apropos of 42 cases]J L Lefebvre, B Vankemmel, J Meynadier, et al.Bulletin Du Cancer|January 1, 1979
Antitumor activity of alkylesters of 1-beta-D-ribofuranosyl-5-fluorouracil-5'-phosphate against murine lymphoma L5178Y resistant to 1-beta-D-ribofuranosyl-5-fluorouracilF Kanzawa, A Hoshi, K KuretaniBulletin Du Cancer|January 1, 1975
[Chromosome aberrations induced by bleomycin in human lymphocytes in vitro]F Hayez-Delatte, W FeremansBulletin Du Cancer|December 1, 1994
[Bleomycin is an antineoplastic agent capable of mimicking apoptosis]O Tounekti, J Belehradek, L M MirBulletin Du Cancer|January 1, 1995
[Clinical value of the potential doubling time (Tpot) measured by flow cytometry]B Dubray, Z Maciorowsky, J M Cosset, et al.Pageof 544